The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
A metabolic pathway for bile acid dehydroxylation by the gut microbiome
Open accessPublished version of a preprint
Abstract
The gut microbiota synthesize hundreds of molecules, many of which influence host physiology. Among the most abundant metabolites are the secondary bile acids deoxycholic acid (DCA) and lithocholic acid (LCA), which accumulate at concentrations of around 500 μM and are known to block the growth of Clostridium difficile 1, promote hepatocellular carcinoma 2 and modulate host metabolism via the G-protein-coupled receptor TGR5 (ref. 3). More broadly, DCA, LCA and their derivatives are major components of the recirculating pool of bile acids 4; the size and composition of this pool are a target of therapies for primary biliary cholangitis and nonalcoholic steatohepatitis. Nonetheless, despite the clear impact of DCA and LCA on host physiology, an incomplete knowledge of their biosynthetic genes and a lack of genetic tools to enable modification of their native microbial producers limit our ability to modulate secondary bile acid levels in the host. Here we complete the pathway to DCA and LCA by assigning and characterizing enzymes for each of the steps in its reductive arm, revealing a strategy in which the A-B rings of the steroid core are transiently converted into an electron acceptor for two reductive steps carried out by Fe-S flavoenzymes. Using anaerobic in vitro reconstitution, we establish that a set of six enzymes is necessary and sufficient for the eight-step conversion of cholic acid to DCA. We then engineer the pathway into Clostridium sporogenes, conferring production of DCA and LCA on a nonproducing commensal and demonstrating that a microbiome-derived pathway can be expressed and controlled heterologously. These data establish a complete pathway to two central components of the bile acid pool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bacteria in the gastrointestinal tract produce amino acid bile acid amidates that can affect host-mediated metabolic processes1–6; however, the bacterial gene(s) responsible for their production remain unknown.”
From Bile Acids Are Substrates for Amine N-Acyl Transferase Activity by Bile Salt Hydrolase (2022) · cites this paper as [5]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Yu, D., Schilter, H. C., Rolph, M. S., Mackay, F., Artis, D., et al. (2009) · Nature · doi:10.1038/nature08530 · Cited by 3,241
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Wahlstrom, A. M., Sayin, S. I., Marschall, H., & Bäckhed, F. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.005 · Cited by 2,969
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Bouatra, S., Aziat, F., Mandal, R., Guo, A. C., Wilson, M. R., Knox, C., Bjorndahl, T. C., Krishnamurthy, R., Saleem, F., Liu, P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073076 · Cited by 1,457
Bile acid metabolites control TH17 and Treg cell differentiation
Hang, S., Paik, D., Yao, L., Kim, E., Trinath, J., Lu, J., Ha, S., Nelson, B. N., Kelly, S. P., Wu, L., et al. (2019) · Nature · doi:10.1038/s41586-019-1785-z · Cited by 1,457
Self-citation
Cited by
Sorted by citations
Gut microbial metabolites as multi-kingdom intermediates
Krautkramer, K. A., Fan, J., & Bäckhed, F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0438-4 · Cited by 1,398
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D., & Patterson, A. D. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00805-x · Cited by 1,214
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Cai, J., Sun, L., & Gonzalez, F. J. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.02.004 · Cited by 881
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
Review: microbial transformations of human bile acids
Guzior, D. V., & Quinn, R. A. (2021) · Microbiome · doi:10.1186/s40168-021-01101-1 · Cited by 788
Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians
Sato, Y., Atarashi, K., Plichta, D. R., Arai, Y., Sasajima, S., Kearney, S. M., Suda, W., Takeshita, K., Sasaki, T., Okamoto, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03832-5 · Cited by 632
Self-citationThe role of the gut microbiome and its metabolites in metabolic diseases
Wu, J., Wang, K., Wang, X., Pang, Y., & Jiang, C. (2020) · Protein & Cell · doi:10.1007/s13238-020-00814-7 · Cited by 592
Fleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 596
Bile acid metabolism and signaling, the microbiota, and metabolic disease
Cai, J., Rimal, B., Jiang, C., Chiang, J. Y. L., & Patterson, A. D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108238 · Cited by 529
Sorbara, M. T., & Pamer, E. G. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00667-9 · Cited by 468
Immunological mechanisms of inflammatory diseases caused by gut microbiota dysbiosis: A review
Zhao, M., Chu, J., Feng, S., Guo, C., Xue, B., He, K., & Li, L. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114985 · Cited by 510
Self-citationGut symbionts alleviate MASH through a secondary bile acid biosynthetic pathway
Nie, Q., Luo, X., Wang, K., Ding, Y., Jia, S., Zhao, Q., Li, M., Zhang, J., Zhuo, Y., Lin, J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.03.034 · Cited by 356
Self-citationCong, J., Liu, P., Han, Z., Ying, W., Li, C., Yang, Y., Wang, S., Yang, J., Cao, F., Shen, J., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.014 · Cited by 327
Self-citationA bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1
Li, W., Hang, S., Fang, Y., Bae, S., Zhang, Y., Zhang, M., Wang, G., McCurry, M. D., Bae, M., Paik, D., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.07.013 · Cited by 306
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 314
Design, construction, and in vivo augmentation of a complex gut microbiome
Cheng, A. G., Ho, P.-Y., Aranda-Díaz, A., Jain, S., Yu, F. B., Meng, X., Wang, M., Iakiviak, M., Nagashima, K., Zhao, A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.08.003 · Cited by 279
Self-citationBile Acids Are Substrates for Amine N-Acyl Transferase Activity by Bile Salt Hydrolase
Patterson, A., Rimal, B., Collins, S., Granda, M., Koo, I., Solanka, S., Hoque, N., Gentry, E., Yan, T., Bisanz, J., et al. (2022) · doi:10.21203/rs.3.rs-2050120/v1 · Cited by 252
Lee, J. W. J., Plichta, D. R., Hogstrom, L. J., Borren, N. Z., Lau, H., Gregory, S. M., Tan, W., Khalili, H., Clish, C. B., Vlamakis, H. C., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.019 · Cited by 245
Metabolic Messengers: bile acids
Perino, A., & Schoonjans, K. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00559-z · Cited by 223
Guan, B., Tong, J., Hao, H., Yang, Z., Chen, K., Xu, H., & Wang, A. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.011 · Cited by 212
Interactive relationships between intestinal flora and bile acids
Guo, X., Okpara, E. S., Hu, W., Yan, C., Wang, Y., Liang, Q., Chiang, J. Y. L., & Han, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158343 · Cited by 206
Gut bacterial nutrient preferences quantified in vivo
Zeng, X., Xing, X., Gupta, M., Keber, F. C., Lopez, J. G., Lee, Y.-C. J., Roichman, A., Wang, L., Neinast, M. D., Donia, M. S., et al. (2022) · Cell · doi:10.1016/j.cell.2022.07.020 · Cited by 205
Molecular basis of bile acid-FXR-FGF15/19 signaling axis
Katafuchi, T., & Makishima, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116046 · Cited by 193
Another renaissance for bile acid gastrointestinal microbiology
Ridlon, J. M., & Gaskins, H. R. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00896-2 · Cited by 205
Crosstalk between bile acid-activated receptors and microbiome in entero-hepatic inflammation
Thibaut, M. M., & Bindels, L. B. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.12.006 · Cited by 190
Physiology and Physical Chemistry of Bile Acids
di Gregorio, M. C., Cautela, J., & Galantini, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041780 · Cited by 197
A roadmap for metagenomic enzyme discovery
Robinson, S. L., Piel, J., & Sunagawa, S. (2021) · Natural Product Reports · doi:10.1039/d1np00006c · Cited by 195
Li, M., Wang, S., Li, Y., Zhao, M., Kuang, J., Liang, D., Wang, J., Wei, M., Rajani, C., Ma, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29589-7 · Cited by 175
Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome
Jin, W., Li, T., Huo, D., Qu, S., Li, X. V., Arifuzzaman, M., Lima, S. F., Shi, H., Wang, A., Putzel, G., et al. (2022) · Cell · doi:10.1016/j.cell.2021.12.035 · Cited by 183
Self-citationUtilization of the microbiome in personalized medicine
Ratiner, K., Ciocan, D. M., Abdeen, S. K., & Elinav, E. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00998-9 · Cited by 189
Lucas, L. N., Barrett, K., Kerby, R. L., Zhang, Q., Cattaneo, L. E., Stevenson, D., Rey, F. E., & Amador-Noguez, D. (2021) · mSystems · doi:10.1128/msystems.00805-21 · Cited by 168
Perinatal and Early-Life Nutrition, Epigenetics, and Allergy
Acevedo, N., Alhamwe, B. A., Caraballo, L. R., Ding, M., Ferrante, A., Garn, H., Garssen, J., Hii, C. S. T., Irvine, J., Llinás-Caballero, K., et al. (2021) · Nutrients · doi:10.3390/nu13030724 · Cited by 182
Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Su, L., Gao, Y., & Yang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127743 · Cited by 174
The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease
Thomas, J. P., Módos, D., Rushbrook, S., Powell, N., & Korcsmáros, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829525 · Cited by 167
Li, D., Liu, R., Wang, M., Peng, R., Fu, S., Fu, A., Le, J., Yao, Q., Yuan, T., Chi, H., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.01.001 · Cited by 155
Self-citationGut microbiome and bile acids in obesity-related diseases
Li, R., Andreu‐Sánchez, S., Kuipers, F., & Fu, J. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101493 · Cited by 154
Microbiota–neuroepithelial signalling across the gut–brain axis
Ohara, T. E., & Hsiao, E. Y. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01136-9 · Cited by 147
Effect of different bile acids on the intestine through enterohepatic circulation based on FXR
Xiang, J., Zhang, Z., Xie, H., Zhang, C., Bai, Y., Cao, H., Che, Q., Guo, J., & Su, Z. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1949095 · Cited by 142
A microbial metabolite remodels the gut-liver axis following bariatric surgery
Chaudhari, S. N., Luo, J. N., Harris, D. A., Aliakbarian, H., Yao, L., Paik, D., Subramaniam, R., Adhikari, A. A., Vernon, A. H., Kılıç, A., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2020.12.004 · Cited by 143
Nabavi-Rad, A., Sadeghi, A., Aghdaei, H. A., Yadegar, A., Smith, S. M., & Zali, M. R. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2108655 · Cited by 144
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Han, H. L., Jiang, Y., Wang, M., Melaku, M., Liu, L., Zhao, Y. M., Everaert, N., Yi, B., & Zhang, H. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1966738 · Cited by 133
Self-citationMakki, K., Brolin, H., Petersen, N., Henricsson, M., Christensen, D. P., Khan, M. T., Wahlstrom, A. M., Bergh, P., Tremaroli, V., Schoonjans, K., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326541 · Cited by 135
Microbial Metabolites and Gut Immunology
Takeuchi, T., Nakanishi, Y., & Ohno, H. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090222-102035 · Cited by 137
Yan, Y., Yu, L., Qu, Y., Fan, Z., Zhang, T., Xu, Y., Du, Q., Brügger, D., Chen, Y., Zhang, K., et al. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00420-5 · Cited by 136
Characterization of interactions of dietary cholesterol with the murine and human gut microbiome
Le, H. H., Lee, M.-T., Besler, K. R., Comrie, J. M. C., & Johnson, E. L. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01195-9 · Cited by 126
Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids
Liu, C., Du, M., Xie, L., Wang, W.-Z., Chen, B., Yun, C., Sun, X., Luo, X., Jiang, Y., Wang, K., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-023-01570-0 · Cited by 129
Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling
Wang, Q., Lin, H., Shen, C., Zhang, M., Wang, X., Yuan, M., Yuan, M., Jia, S., Cao, Z., Wu, C., et al. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2274124 · Cited by 126
gutSMASH predicts specialized primary metabolic pathways from the human gut microbiota
Andreu, V., Augustijn, H. E., Chen, L., Zhernakova, A., Fu, J., Fischbach, M. A., Dodd, D., & Medema, M. H. (2023) · Nature Biotechnology · doi:10.1038/s41587-023-01675-1 · Cited by 123
Self-citationMasse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
“The remaining bile acids that escape absorption in the small intestine (5%) act as substrates for anaerobic metabolism in the colon (15, 60) or are excreted with feces.”
BackgroundThe potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease
Chakaroun, R., Olsson, L. M., & Bäckhed, F. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00771-0 · Cited by 126
Bile acids as inflammatory mediators and modulators of intestinal permeability
Calzadilla, N., Comiskey, S., Dudeja, P. K., Saksena, S., Gill, R. K., & Alrefai, W. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1021924 · Cited by 123
Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega
Doden, H. L., & Ridlon, J. M. (2021) · Microorganisms · doi:10.3390/microorganisms9030469 · Cited by 113
Koh, E., Hwang, I. Y., Lee, H. L., Sotto, R. D., Lee, J. W. J., Lee, Y. S., March, J. C., & Chang, M. W. (2022) · Nature Communications · doi:10.1038/s41467-022-31334-z · Cited by 116
Physiological Role of Bile Acids Modified by the Gut Microbiome
Kiriyama, Y., & Nochi, H. (2021) · Microorganisms · doi:10.3390/microorganisms10010068 · Cited by 104
Regulation of bile acids and their receptor FXR in metabolic diseases
Li, Y., Wang, L., Qing, Y., Luo, L., & Xiong, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1447878 · Cited by 117
Bile acid-independent protection against Clostridioides difficile infection
Aguirre, A. M., Yalçınkaya, N., Wu, Q., Swennes, A. G., Tessier, M. E. M., Roberts, P., Miyajima, F., Savidge, T., & Sorg, J. A. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010015 · Cited by 95
Zou, Y., Wang, S., Zhang, H., Gu, Y., Chen, H., Huang, Z., Yang, F., Li, W., Chen, C., Men, L., et al. (2023) · Medicinal Research Reviews · doi:10.1002/med.21989 · Cited by 97
The central role of the gut microbiota in the pathophysiology and management of type 2 diabetes
Baars, D. P., Fondevila, M. F., Meijnikman, A. S., & Nieuwdorp, M. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.017 · Cited by 111
Wise, J. L., & Cummings, B. P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1093420 · Cited by 94
Trivedi, P. J., Hirschfield, G. M., Adams, D., & Vierling, J. M. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.01.049 · Cited by 101
Zhang, Y., Li, Y., Lu, P., Dai, G.-C., Chen, X.-X., & Rui, Y. (2021) · Food & Function · doi:10.1039/d0fo03468a · Cited by 92
Host metabolism balances microbial regulation of bile acid signalling
Won, T. H., Arifuzzaman, M., Parkhurst, C. N., Miranda, I. C., Zhang, B., Hu, E., Kashyap, S., Letourneau, J., Jin, W., Fu, Y., et al. (2025) · Nature · doi:10.1038/s41586-024-08379-9 · Cited by 98
Self-citationLi, X., Shang, S., Wu, M., Song, Q., & Chen, D. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217096 · Cited by 84
Sulfated bile acid is a host-derived ligand for MAIT cells
Ito, E., Inuki, S., Izumi, Y., Takahashi, M., Dambayashi, Y., Ciacchi, L., Awad, W., Takeyama, A., Shibata, K., Mori, S., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.ade6924 · Cited by 77
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 85
Yang, K., Li, G., Li, Q., Wang, W., Zhao, X. X., Shao, N., Qiu, H., Liu, J., Xu, L., & Zhao, J. (2025) · Cell & Bioscience · doi:10.1186/s13578-025-01385-y · Cited by 99
DT-109 ameliorates nonalcoholic steatohepatitis in nonhuman primates
Qu, P., Rom, O., Li, K., Jia, L., Gao, X., Liu, Z., Ding, S., Zhao, M., Wang, H., Chen, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.013 · Cited by 78
Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis
Pan, Y., Zhang, H., Li, M., He, T., Guo, S., Zhu, L., Tan, J., & Wang, B. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2356284 · Cited by 84
The gut microbiota–bile acid axis: A potential therapeutic target for liver fibrosis
Zhang, Y., Li, Z.-J., Gou, H.-Z., Song, X., & Zhang, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.945368 · Cited by 77
Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome
Wang, M., Osborn, L. J., Jain, S., Meng, X., Weakley, A. M., Yan, J., Massey, W. J., Varadharajan, V., Horak, A. J., Banerjee, R., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.037 · Cited by 74
Self-citationWahlstrom, A. M., Brumbaugh, A. R., Sjöland, W., Olsson, L. M., Wu, H., Henricsson, M., Lundqvist, A., Makki, K., Hazen, S. L., Bergström, G. M. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48543-3 · Cited by 76
Self-citationYe, X., Huang, D., Dong, Z., Wang, X., Ning, M., Xia, J. L., Shen, S., Wu, S., Shi, Y. X., Wang, J., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00518-22 · Cited by 71
Formation of secondary allo-bile acids by novel enzymes from gut Firmicutes
Lee, J., Cowley, E. S., Wolf, P. G., Doden, H. L., Murai, T., Caicedo, K. Y. O., Ly, L. K., Sun, F.-R., Takei, H., Nittono, H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2132903 · Cited by 71
Research on Gut Microbiota-Derived Secondary Bile Acids in Cancer Progression
Yang, R., & Li, Q. (2022) · Integrative Cancer Therapies · doi:10.1177/15347354221114100 · Cited by 72
Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis
Aliwa, B. O., Horvath, A., Traub, J., Feldbacher, N., Habisch, H., Fauler, G., Madl, T., & Stadlbauer, V. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13342 · Cited by 70
Andreu, V. P., Roel‐Touris, J., Dodd, D., Fischbach, M. A., & Medema, M. H. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab353 · Cited by 62
Self-citationBile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
Gadaleta, R. M., Cariello, M., Crudele, L., & Moschetta, A. (2022) · Nutrients · doi:10.3390/nu14153212 · Cited by 67
Stutz, M. R., Dylla, N. P., Pearson, S. D., Lecompte-Osorio, P. A., Nayak, R., Khalid, M., Adler, E., Boissiere, J. C., Lin, H., Leiter, W. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34260-2 · Cited by 64
Zhang, H., Xie, Y., Cao, F., & Song, X. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2382336 · Cited by 71
Pan, Z., Hu, Y., Huang, Z., Han, N., Li, Y., Zhuang, X., Yin, J., Peng, H., Gao, Q., Zhang, W., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2056-1 · Cited by 64
Genetic Engineering of Resident Bacteria in the Gut Microbiome
Arnold, J. H., Glazier, J., & Mimee, M. (2023) · Journal of Bacteriology · doi:10.1128/jb.00127-23 · Cited by 63
Flavonoids, gut microbiota, and host lipid metabolism
Zhou, M., Ma, J., Kang, M., Tang, W., Xia, S., Yin, J., & Yin, Y. (2023) · Engineering in Life Sciences · doi:10.1002/elsc.202300065 · Cited by 68
Effect of Gut Microbiota on Blood Cholesterol: A Review on Mechanisms
Deng, C., Pan, J., Zhu, H., & Chen, Z. (2023) · Foods · doi:10.3390/foods12234308 · Cited by 70
Xu, Y., Wang, J., Wu, X., Jing, H., Zhang, S., Hu, Z., Rao, L., Chang, Q., Wang, L., & Zhang, Z. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2168101 · Cited by 61
Xu, Y., Jing, H., Wang, J., Zhang, S., Chang, Q., Li, Z., Wu, X., & Zhang, Z. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.800604 · Cited by 62
Identification and Characterization of Major Bile Acid 7α-Dehydroxylating Bacteria in the Human Gut
Kim, K. H., Park, D., Jia, B., Baek, J. H., Hahn, Y., & Jeon, C. O. (2022) · mSystems · doi:10.1128/msystems.00455-22 · Cited by 65
Zhou, C., Wang, Y., Li, C., Xie, Z., & Dai, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03330-22 · Cited by 65
The gut microbiota-bile acid axis: a crucial regulator of immune function and metabolic health
Tyagi, A., & Kumar, V. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04395-7 · Cited by 68
Helf, M. J., Fox, B. W., Artyukhin, A. B., Zhang, Y. K., & Schroeder, F. C. (2022) · Nature Communications · doi:10.1038/s41467-022-28391-9 · Cited by 59
Recent advances in metabolism and toxicity of tyrosine kinase inhibitors
Zhao, Q., Wu, Z. E., Li, B., & Li, F. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108256 · Cited by 57
Zhao, M., Jiafeng, Z., Yang, H., Ouyang, Z., Lv, C., Geng, Z., & Zhao, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118182 · Cited by 69
Yu, Y., Ding, Y., Wang, S., & Jiang, L. (2025) · Metabolites · doi:10.3390/metabo15060397 · Cited by 71
Yan, W., Zhang, K., Guo, J., & Xu, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595486 · Cited by 60
New Insights into Bile Acids Related Signaling Pathways in the Onset of Colorectal Cancer
Caliceti, C., Punzo, A., Silla, A., Simoni, P., Roda, G., & Hrelia, S. (2022) · Nutrients · doi:10.3390/nu14142964 · Cited by 51
The Hylemon-Björkhem pathway of bile acid 7-dehydroxylation: history, biochemistry, and microbiology
Ridlon, J. M., Daniel, S. L., & Gaskins, H. R. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100392 · Cited by 51
Wang, Y., Li, Y., Lin, Y., Cao, C.-Y., Chen, D., Huang, X., Li, C., Xu, H., Lai, H., Chen, H., et al. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02413-z · Cited by 56
Enteral nutrition promotes the remission of colitis by gut bacteria-mediated histidine biosynthesis
Zeng, W., Wu, J., Xie, H., Xu, H., Liang, D., He, Q., Yang, X., Liu, C., Gong, J., Zhang, Q., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2023.104959 · Cited by 53
The Gut Microbiome and Ferroptosis in MAFLD
Ji, J., Wu, L., Wei, J., Wu, J., & Guo, C. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2022.00136 · Cited by 50
Self-citationDiosgenin alleviates nonalcoholic steatohepatitis through affecting liver-gut circulation
Yan, M., Man, S., Liang, Y., Ma, L., Guo, L., Huang, L., & Gao, W. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106621 · Cited by 52
Reed, A. D., Nethery, M. A., Stewart, A. K., Barrangou, R., & Theriot, C. M. (2020) · Journal of Bacteriology · doi:10.1128/jb.00039-20 · Cited by 49
Metadata
- Authors
- Funabashi, M., Grove, T. L., Wang, M., Varma, Y., McFadden, M. E., Brown, L. C., Guo, C., Higginbottom, S., Almo, S. C., & Fischbach, M. A.
- Affiliations
- Daiichi Sankyo RD Novare (Japan) (JP)
- Albert Einstein College of Medicine (US)
- Stanford University (US)
- Indiana University Bloomington (US)
- Stanford Medicine (US)
- Chan Zuckerberg Biohub San Francisco (US)
- Corresponding author
- Almo, Steven C.
- Fischbach, Michael A.
- ORCID
- Venue
- Nature
- Published
- 2020-06-17
- Volume
- 582
- Issue
- 7813
- Pages
- 566-570
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7319900
- OpenAlex
- W3036012425
- Cited by
- 590
- References
- 46
- Citations by year
- 2026: 125 · 2025: 108 · 2024: 123 · 2023: 89 · 2022: 78 · 2021: 53 · 2020: 13
- FWCI
- 18.90
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Nature (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Price Family Foundation
- National Institutes of Health (1dp2hd101401-01, GM093342, DK113598, DK110174, GM094662)
- National Heart, Lung, and Blood Institute (P01HL147823)
- National Institute of General Medical Sciences (U54GM093342, U54GM094662, P01GM118303)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK110174, DP1DK113598, R01DK101674)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (DP2 HD101401)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Keywords
- secondary bile acids, deoxycholic acid, lithocholic acid, gut microbiota, reductive dehydroxylation, cholic acid, Clostridium sporogenes, heterologous pathway expression, germ-free mice, primary biliary cirrhosis, nonalcoholic steatohepatitis, TGR5
- MeSH terms
- Gastrointestinal Microbiome, Animals, Bile Acids and Salts, Clostridium, Deoxycholic Acid, Hydroxylation, Lithocholic Acid, Male, Operon, Symbiosis, Mice, Metabolic Networks and Pathways, Metabolic Engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
